Aims: Diabetic foot results in frequent amputation and quality-of-life reduction in diabetes population. These lesions are featured by a prolonged and exaggerated inflammation with a significant impairment in local bacterial invasion. Negative pressure wound therapy (NPWT) attenuates hyperinflammation in the healing of diabetic foot wounds, but the potential mechanism of NPWT down-regulated inflammatory reaction still remains elusive. This study aims to explore the inflammatory signaling involved in the effect of NPWT on diabetic ulcer. Methods: Thirty patients with diabetic foot ulceration were divided into NPWT group (treated with NPWT, n = 10), NPWT + FK565 group (treated with NPWT combined with FK565 which is NOD1 receptor ligand, n = 10) and control group (n = 10). After two weeks treatment, samples were harvested and analyzed by histochemistry for infiltration of inflammatory cells, immunofluorescence stain for NOD1, western blotting for NOD1, RIP2 (Receptor interacting protein 2), IL-1β, TAK1 (Transforming growth factor-β-activated kinase1), p65 and real time-PCR for expression of NOD1 and RIP2. Results: NPWT could notably accelerate the diabetic wound healing through alleviating inflammatory reaction. The immunofluorescence analysis results revealed that NOD1 was mainly expressed in the cytoplasm and noticeably decreased after the NPWT treatment. And NPWT obviously decreased both the mRNA and protein level of NOD1 and RIP2. Moreover, The protein expression of IL-1β, TAK1 and p65 in the NPWT-group were significant decreased. Conclusion: NPWT effectively promotes wound healing by suppressing the wound inflammation in diabetic foot, which is mediated at least in part by suppression of NOD1 receptor.
KlopfJBrostjanCEilenbergWNeumayerC. Neutrophil extracellular traps and their implications in cardiovascular and inflammatory disease. Int J Mol Sci. 2021;22(2):559.
2.
BilirFChkhikvadzeMYilmazAYKoseOAriozDT. Prognostic value of systemic inflammation response index in patients with persistent human papilloma virus infection. Ginekol Pol. 2022; 93(9):705‐709.
3.
ZhuFDuanWZhongCJiBLiuX. The protective effects of dezocine on interleukin-1beta-induced inflammation, oxidative stress and apoptosis of human nucleus pulposus cells and the possible mechanisms. Bioengineered. 2022;13(1):1399‐1410.
4.
BanEJeongSParkM, et al.Accelerated wound healing in diabetic mice by miRNA-497 and its anti-inflammatory activity. Biomed Pharmacother. 2020;121(1):109613.
5.
BlakytnyRJudeEB. Altered molecular mechanisms of diabetic foot ulcers. Int J Low Extrem Wounds. 2009;8(2):95‐104.
6.
WangTZhaoJZhangJ, et al.Heparan sulfate inhibits inflammation and improves wound healing by downregulating the NLR family pyrin domain containing 3(NLRP3) inflammasome in diabetic rats. J Diabetes. 2018;10(7):556‐563.
7.
KirsnerRSZimnitskyDRobinsonM. A prospective, randomized, controlled clinical study on the effectiveness of a single-use negative pressure wound therapy system, compared to traditional negative pressure wound therapy in the treatment of diabetic ulcers of the lower extremities. Wound Repair Regen. 2021;29(6):908‐911.
8.
Bueno-Lledó1JFranco-BernalAGarcia-Voz-MedianoMTTorregrosa-GalludABonaféS. Prophylactic single-use negative pressure dressing in closed surgical wounds after incisional hernia repair: A randomized, controlled trial. Ann Surg. 2021;273(6):1081‐1086.
9.
LiH-ZXuX-HWangD-W, et al.Negative pressure wound therapy for surgical site infections: A systematic review and meta-analysis of randomized controlled trials. Clin Microbiol Infect. 2019;25(11):1328‐1338.
10.
KubiakBDAlbertSPGattoLA, et al.Peritoneal negative pressure therapy prevents multiple organ injury in a chronic porcine sepsis and ischemia/reperfusion model. Shock. 2010;34(5):525‐534.
11.
NorburyKKieswetterK. Vacuum-assisted closure therapy attenuates the inflammatory response in a porcine acute wound healing model. Wounds. 2007;19(4):97‐106.
12.
GirardinSEBonecaIGCarneiroLA, et al.Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science. 2003;300(5625):1584‐1587.
13.
da CorreiaJMirandaYLeonardNHsuJUlevitchRJ. Regulation of Nod1-mediated signaling pathways. Cell Death and Differentitation. 2007;14(4):830‐839.
14.
LipskyBABerendtARCorniaPB, et al.2012 Infectious diseases society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012;54(12):e132‐e173.
15.
ElhageKGAwadMEIrfanFB, et al.Closed-incision negative pressure therapy at −125 mm Hg significantly reduces surgical site complications following total hip and knee arthroplasties: A stratified meta-analysis of randomized controlled trials. Health Sci Rep. 2022;5(1):e425.
16.
SatoTShikamaYShimauchiHEndoYTakadaH. Analgesic effects of chemically synthesized NOD1 and NOD2 agonists in mice. Innate Immun. 2011;17(1):54‐59.
17.
LiuDZhangLLiT, et al.Negative-pressure wound therapy enhances local inflammatory responses in acute infected soft-tissue wound. Cell Biochem Biophys. 2014;70(1):539‐547.
18.
KimSPiaoJHwangDYParkJSSonYHongHS. Substance P accelerates wound repair by promoting neovascularization and preventing inflammation in an ischemia mouse model. Life Sci. 2019;225(5):98‐106.
19.
VendidandalaNRYinTPNelliGPasupuletiVRNyamathullaSMokhtarSI. Gallocatechin-silver nanoparticle impregnated cotton gauze patches enhance wound healing in diabetic rats by suppressing oxidative stress and inflammation via modulating the Nrf2/HO-1 and TLR4/NF-κappaB pathways. Life Sci. 2021;286(12):120019.
20.
SongHXuYChangWZhuangJWuX. Negative pressure wound therapy promotes wound healing by suppressing macrophage inflammation in diabetic ulcers. Regen Med. 2020;15(12):2341‐2349.
21.
TeixeiraQEFerreiraDCda SilvaAMP, et al.Aging as a risk factor on the immunoexpression of pro-inflammatory IL-1beta, IL-6 and TNF-alpha cytokines in chronic apical periodontitis lesions. Biology (Basel). 2021;11(1):14.
22.
LiZYuQWangS, et al.Impact of negative-pressure wound therapy on bacterial behaviour and bioburden in a contaminated full-thickness wound. Int Wound J. 2019;16(5):1214‐1221.
23.
WangTLiXFanL, et al.Negative pressure wound therapy promoted wound healing by suppressing inflammation via down-regulating MAPK-JNK signaling pathway in diabetic foot patients. Diabetes Res Clin Pract.2019;150(2):81‐89.
24.
SanoHIchiokaS. Involvement of nitric oxide in the wound bed microcirculatory change during negative pressure wound therapy. International Mound Journal. 2015;12(4):397‐401.
25.
MukherjeeTHovinghESFoersterEGAbdel-NourMPhilpottDJGirardinSE. NOD1 And NOD2 in inflammation, immunity and disease. Arch Biochem Biophys. 2019;670(7):69‐81.
26.
BuchholzKRStephensRS. The cytosolic pattern recognition receptor NOD1 induces inflammatory interleukin-8 during Chlamydia trachomatis infection. Infect Immun. 2008;76(7):3150‐3155.
27.
HuangWGouFLongY, et al.High glucose and lipopolysaccharide activate NOD1-RICK-NF-κB inflammatory signaling in Mesangial cells. Exp Clin Endocrinol Diabetes. 2016;124(8):512‐517.
28.
LinHBNaitoKOhY, et al.Innate immune Nod1/RIP2 signaling is essential for cardiac hypertrophy but requires mitochondrial antiviral signaling protein for signal transductions and energy balance. Circulation. 2020;142(23):2240‐2258.
29.
ZhangCHsuACPanH, et al.Columbianadin suppresses lipopolysaccharide (LPS)-induced inflammation and apoptosis through the NOD1 pathway. Molecules. 2019;24(3):549.
30.
CostelloJPAmlingJKEmersonDA, et al.Negative pressure wound therapy for sternal wound infections following congenital heart surgery. J. Wound Care. 2014;23(1):31‐36.
31.
HphamOLeeBLabudaJ, et al.NOD1/NOD2 And RIP2 regulate endoplasmic reticulum stress-induced inflammation during chlamydia infection. Host Microbe Biology. 2020;11(3):e00979‐20.
